Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2024

Open Access 01-12-2024 | Obesity | Research

Dietary amino acid patterns and cardiometabolic risk factors among subjects with obesity; a cross-sectional study

Authors: Fatemeh Abdi, Milad Mohammadzadeh, Mahdieh Abbasalizad-Farhangi

Published in: BMC Endocrine Disorders | Issue 1/2024

Login to get access

Abstract

Background

The prevalence of obesity is a growing global public health concern. Certain dietary amino acids have been shown to have a potential therapeutic role in improving metabolic syndrome parameters and body composition in individuals with obesity. However, some amino acids have been linked to an increased risk of cardiometabolic disorders. This cross-sectional study aims to investigate the association between dietary amino acid patterns and cardiometabolic risk factors in individuals with obesity.

Methods

This cross-sectional study included 335 participants with obesity (57.9% males and 41.5% females) from Tabriz and Tehran, Iran. The participants were between the ages of 20–50, with a body mass index (BMI) of 30 kg/m2 or higher, and free from certain medical conditions. The study examined participants’ general characteristics, conducted anthropometric assessments, dietary assessments, and biochemical assessments. The study also used principal component analysis to identify amino acid intake patterns and determined the association between these patterns and cardiometabolic risk factors in individuals with obesity.

Results

Upon adjusting for potential confounders, the study found that individuals in the third tertiles of pattern 1 and 2 were more likely to have lower LDL levels (OR = 0.99 and 95% CI (0.98–0.99)) for both. Additionally, a significant decrease in total cholesterol was observed in the third tertiles of pattern 2 in model II (OR = 0.99, 95% CI (0.98–0.99)). These findings suggest a potential cardioprotective effect of these amino acid patterns in managing cardiometabolic risk factors in individuals with obesity.

Conclusions

This study found that two identified amino acid patterns were associated with lower serum LDL and total cholesterol levels, while a third pattern was associated with higher serum triglycerides. The specific amino acids contributing to these patterns highlight the importance of targeted dietary interventions in managing cardiometabolic risk factors in individuals with obesity.
Literature
1.
go back to reference Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022;133:155217.PubMedPubMedCentralCrossRef Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022;133:155217.PubMedPubMedCentralCrossRef
2.
go back to reference Gao X, et al. Higher dietary choline and betaine intakes are associated with better body composition in the adult population of Newfoundland, Canada. PLoS One. 2016;11(5):e0155403.PubMedPubMedCentralCrossRef Gao X, et al. Higher dietary choline and betaine intakes are associated with better body composition in the adult population of Newfoundland, Canada. PLoS One. 2016;11(5):e0155403.PubMedPubMedCentralCrossRef
3.
go back to reference Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016;22(7 Suppl):s176–85.PubMed Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016;22(7 Suppl):s176–85.PubMed
5.
go back to reference Tabrizi JS, et al. Prevalence of dyslipidemia in urban and rural areas of the Northwest of Iran: the sociodemographic, dietary and psychological determinants. Iran J Public Health. 2019;48(5):925.MathSciNetPubMedPubMedCentral Tabrizi JS, et al. Prevalence of dyslipidemia in urban and rural areas of the Northwest of Iran: the sociodemographic, dietary and psychological determinants. Iran J Public Health. 2019;48(5):925.MathSciNetPubMedPubMedCentral
6.
go back to reference Poirier P, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113(6):898–918.PubMedCrossRef Poirier P, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113(6):898–918.PubMedCrossRef
7.
go back to reference Forouzanfar MH, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1659–724.CrossRef Forouzanfar MH, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1659–724.CrossRef
9.
go back to reference Samodien E, et al. Diet-induced DNA methylation within the hypothalamic arcuate nucleus and dysregulated leptin and insulin signaling in the pathophysiology of obesity. Food Sci Nutr. 2019;7(10):3131–45.PubMedPubMedCentralCrossRef Samodien E, et al. Diet-induced DNA methylation within the hypothalamic arcuate nucleus and dysregulated leptin and insulin signaling in the pathophysiology of obesity. Food Sci Nutr. 2019;7(10):3131–45.PubMedPubMedCentralCrossRef
11.
go back to reference Yu L, et al. Association between dietary essential amino acids intake and metabolic biomarkers: influence of obesity among Chinese children and adolescents. Amino Acids. 2021;53(5):635–44.PubMedCrossRef Yu L, et al. Association between dietary essential amino acids intake and metabolic biomarkers: influence of obesity among Chinese children and adolescents. Amino Acids. 2021;53(5):635–44.PubMedCrossRef
12.
14.
go back to reference Jennings A, et al. Amino acid intakes are inversely associated with arterial stiffness and central blood pressure in women. J Nutr. 2015;145(9):2130–8.PubMedPubMedCentralCrossRef Jennings A, et al. Amino acid intakes are inversely associated with arterial stiffness and central blood pressure in women. J Nutr. 2015;145(9):2130–8.PubMedPubMedCentralCrossRef
15.
go back to reference Altorf-van der Kuil W, et al. Dietary amino acids and the risk of hypertension in a Dutch older population: the Rotterdam study. Am J Clin Nutr. 2013;97(2):403–10.PubMedCrossRef Altorf-van der Kuil W, et al. Dietary amino acids and the risk of hypertension in a Dutch older population: the Rotterdam study. Am J Clin Nutr. 2013;97(2):403–10.PubMedCrossRef
16.
go back to reference Tuttle KR, et al. Dietary amino acids and blood pressure: a cohort study of patients with cardiovascular disease. Am J Kidney Dis. 2012;59(6):803–9.PubMedCrossRef Tuttle KR, et al. Dietary amino acids and blood pressure: a cohort study of patients with cardiovascular disease. Am J Kidney Dis. 2012;59(6):803–9.PubMedCrossRef
17.
go back to reference Bahadoran Z, et al. Dietary L-arginine intake and the incidence of coronary heart disease: Tehran lipid and glucose study. Nutr Metab. 2016;13(1):1–9.MathSciNetCrossRef Bahadoran Z, et al. Dietary L-arginine intake and the incidence of coronary heart disease: Tehran lipid and glucose study. Nutr Metab. 2016;13(1):1–9.MathSciNetCrossRef
18.
go back to reference Mone P, et al. L-Arginine enhances the effects of cardiac rehabilitation on physical performance: new insights for managing cardiovascular patients during the COVID-19 pandemic. J Pharmacol Exp Ther. 2022;381(3):197–203.PubMedPubMedCentralCrossRef Mone P, et al. L-Arginine enhances the effects of cardiac rehabilitation on physical performance: new insights for managing cardiovascular patients during the COVID-19 pandemic. J Pharmacol Exp Ther. 2022;381(3):197–203.PubMedPubMedCentralCrossRef
19.
go back to reference Mokhtari E, et al. The association between dietary amino acids and the risk of nonalcoholic fatty liver disease among Tehranian adults: a case-control study. BMC Nutr. 2022;8(1):155.PubMedPubMedCentralCrossRef Mokhtari E, et al. The association between dietary amino acids and the risk of nonalcoholic fatty liver disease among Tehranian adults: a case-control study. BMC Nutr. 2022;8(1):155.PubMedPubMedCentralCrossRef
20.
go back to reference Katsiki N, Mikhailidis DP, Mantzoros CS. Non-alcoholic fatty liver disease and dyslipidemia: an update. Metabolism. 2016;65(8):1109–23.PubMedCrossRef Katsiki N, Mikhailidis DP, Mantzoros CS. Non-alcoholic fatty liver disease and dyslipidemia: an update. Metabolism. 2016;65(8):1109–23.PubMedCrossRef
22.
go back to reference Rom O, et al. Atherogenicity of amino acids in the lipid-laden macrophage model system in vitro and in atherosclerotic mice: a key role for triglyceride metabolism. J Nutr Biochem. 2017;45:24–38.PubMedCrossRef Rom O, et al. Atherogenicity of amino acids in the lipid-laden macrophage model system in vitro and in atherosclerotic mice: a key role for triglyceride metabolism. J Nutr Biochem. 2017;45:24–38.PubMedCrossRef
23.
go back to reference AbbasalizadFarhangi M, et al. Interaction between vascular endothelial growth factor-A (rs2010963) gene polymorphisms and dietary diversity score on cardiovascular risk factors in patients with metabolic syndrome. Lifestyle Genom. 2020;13(1):1–10.CrossRef AbbasalizadFarhangi M, et al. Interaction between vascular endothelial growth factor-A (rs2010963) gene polymorphisms and dietary diversity score on cardiovascular risk factors in patients with metabolic syndrome. Lifestyle Genom. 2020;13(1):1–10.CrossRef
24.
go back to reference Khodarahmi M, Asghari-Jafarabadi M, AbbasalizadFarhangi M. A structural equation modeling approach for the association of a healthy eating index with metabolic syndrome and cardio-metabolic risk factors among obese individuals. PLoS One. 2019;14(7):e0219193.PubMedPubMedCentralCrossRef Khodarahmi M, Asghari-Jafarabadi M, AbbasalizadFarhangi M. A structural equation modeling approach for the association of a healthy eating index with metabolic syndrome and cardio-metabolic risk factors among obese individuals. PLoS One. 2019;14(7):e0219193.PubMedPubMedCentralCrossRef
25.
go back to reference Murray AE, et al. Dietary quality in a sample of adults with type 2 diabetes mellitus in Ireland; a cross-sectional case control study. Nutr J. 2013;12:1–11.CrossRef Murray AE, et al. Dietary quality in a sample of adults with type 2 diabetes mellitus in Ireland; a cross-sectional case control study. Nutr J. 2013;12:1–11.CrossRef
26.
go back to reference Washburn RA. Assessment of physical activity in older adults. Res Q Exerc Sport. 2000;71(sup2):79–87.PubMedCrossRef Washburn RA. Assessment of physical activity in older adults. Res Q Exerc Sport. 2000;71(sup2):79–87.PubMedCrossRef
27.
go back to reference Flint A, et al. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes. 2000;24(1):38–48.CrossRef Flint A, et al. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes. 2000;24(1):38–48.CrossRef
28.
go back to reference Mirmiran P, et al. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654–62.PubMedCrossRef Mirmiran P, et al. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654–62.PubMedCrossRef
29.
go back to reference Ghaffarpour M, Houshiar-Rad A, Kianfar H. The manual for household measures, cooking yields factors and edible portion of foods. Tehran Nashre Olume Keshavarzy. 1999;7(213):42–58. Ghaffarpour M, Houshiar-Rad A, Kianfar H. The manual for household measures, cooking yields factors and edible portion of foods. Tehran Nashre Olume Keshavarzy. 1999;7(213):42–58.
30.
go back to reference Sampson M, et al. A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and/or hypertriglyceridemia. JAMA Cardiol. 2020;5(5):540–8.PubMedCrossRef Sampson M, et al. A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and/or hypertriglyceridemia. JAMA Cardiol. 2020;5(5):540–8.PubMedCrossRef
31.
go back to reference Jobgen WS, et al. Regulatory role for the arginine–nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem. 2006;17(9):571–88.PubMedCrossRef Jobgen WS, et al. Regulatory role for the arginine–nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem. 2006;17(9):571–88.PubMedCrossRef
32.
go back to reference Hu S, et al. L-arginine modulates glucose and lipid metabolism in obesity and diabetes. Curr Protein Pept Sci. 2017;18(6):599–608.PubMedCrossRef Hu S, et al. L-arginine modulates glucose and lipid metabolism in obesity and diabetes. Curr Protein Pept Sci. 2017;18(6):599–608.PubMedCrossRef
33.
go back to reference Szlas A, Kurek JM, Krejpcio Z. The potential of L-arginine in prevention and treatment of disturbed carbohydrate and lipid metabolism—a review. Nutrients. 2022;14(5):961.PubMedPubMedCentralCrossRef Szlas A, Kurek JM, Krejpcio Z. The potential of L-arginine in prevention and treatment of disturbed carbohydrate and lipid metabolism—a review. Nutrients. 2022;14(5):961.PubMedPubMedCentralCrossRef
35.
go back to reference Yin WH, et al. L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease. Clin Nutr. 2005;24(6):988–97.PubMedCrossRef Yin WH, et al. L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease. Clin Nutr. 2005;24(6):988–97.PubMedCrossRef
36.
go back to reference El-Missiry MA, Othman AI, Amer MA. L-Arginine ameliorates oxidative stress in alloxan-induced experimental diabetes mellitus. J Appl Toxicol. 2004;24(2):93–7.PubMedCrossRef El-Missiry MA, Othman AI, Amer MA. L-Arginine ameliorates oxidative stress in alloxan-induced experimental diabetes mellitus. J Appl Toxicol. 2004;24(2):93–7.PubMedCrossRef
37.
39.
go back to reference Ma W, et al. Dietary glutamine, glutamate and mortality: two large prospective studies in US men and women. Int J Epidemiol. 2018;47(1):311–20.PubMedCrossRef Ma W, et al. Dietary glutamine, glutamate and mortality: two large prospective studies in US men and women. Int J Epidemiol. 2018;47(1):311–20.PubMedCrossRef
41.
go back to reference Senthilkumar R, Sengottuvelan M, Nalini N. Protective effect of glycine supplementation on the levels of lipid peroxidation and antioxidant enzymes in the erythrocyte of rats with alcohol-induced liver injury. Cell Biochem Funct. 2004;22(2):123–8.PubMedCrossRef Senthilkumar R, Sengottuvelan M, Nalini N. Protective effect of glycine supplementation on the levels of lipid peroxidation and antioxidant enzymes in the erythrocyte of rats with alcohol-induced liver injury. Cell Biochem Funct. 2004;22(2):123–8.PubMedCrossRef
42.
go back to reference Meucci E, Mele M. Amino acids and plasma antioxidant capacity. Amino Acids. 1997;12:373–7.CrossRef Meucci E, Mele M. Amino acids and plasma antioxidant capacity. Amino Acids. 1997;12:373–7.CrossRef
43.
go back to reference Teymoori F, et al. Are dietary amino acids prospectively predicts changes in serum lipid profile? Diabetes Metab Syndr. 2019;13(3):1837–43.PubMedCrossRef Teymoori F, et al. Are dietary amino acids prospectively predicts changes in serum lipid profile? Diabetes Metab Syndr. 2019;13(3):1837–43.PubMedCrossRef
44.
go back to reference Watanabe H, Rose MT, Aso H. Role of peripheral serotonin in glucose and lipid metabolism. Curr Opin Lipidol. 2011;22(3):186–91.PubMedCrossRef Watanabe H, Rose MT, Aso H. Role of peripheral serotonin in glucose and lipid metabolism. Curr Opin Lipidol. 2011;22(3):186–91.PubMedCrossRef
45.
go back to reference Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev. 1996;20(1):1–25.PubMedCrossRef Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev. 1996;20(1):1–25.PubMedCrossRef
46.
go back to reference Li F, et al. Leucine nutrition in animals and humans: mTOR signaling and beyond. Amino Acids. 2011;41:1185–93.PubMedCrossRef Li F, et al. Leucine nutrition in animals and humans: mTOR signaling and beyond. Amino Acids. 2011;41:1185–93.PubMedCrossRef
47.
go back to reference Dong Z, et al. Association of sulfur amino acid consumption with cardiometabolic risk factors: cross-sectional findings from NHANES III. EClinicalMedicine. 2020;19:100248.PubMedPubMedCentralCrossRef Dong Z, et al. Association of sulfur amino acid consumption with cardiometabolic risk factors: cross-sectional findings from NHANES III. EClinicalMedicine. 2020;19:100248.PubMedPubMedCentralCrossRef
48.
go back to reference Chambers JC, Obeid OA, Kooner JS. Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects. Arterioscler Thromb Vasc Biol. 1999;19(12):2922–7.PubMedCrossRef Chambers JC, Obeid OA, Kooner JS. Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects. Arterioscler Thromb Vasc Biol. 1999;19(12):2922–7.PubMedCrossRef
49.
go back to reference Verhoef P, et al. Dietary serine and cystine attenuate the homocysteine-raising effect of dietary methionine: a randomized crossover trial in humans. Am J Clin Nutr. 2004;80(3):674–9.PubMedCrossRef Verhoef P, et al. Dietary serine and cystine attenuate the homocysteine-raising effect of dietary methionine: a randomized crossover trial in humans. Am J Clin Nutr. 2004;80(3):674–9.PubMedCrossRef
50.
go back to reference Hirche F, et al. Effect of dietary methionine on plasma and liver cholesterol concentrations in rats and expression of hepatic genes involved in cholesterol metabolism. Br J Nutr. 2006;95(5):879–88.PubMedCrossRef Hirche F, et al. Effect of dietary methionine on plasma and liver cholesterol concentrations in rats and expression of hepatic genes involved in cholesterol metabolism. Br J Nutr. 2006;95(5):879–88.PubMedCrossRef
51.
go back to reference Obeid R, Herrmann W. Homocysteine and lipids: S-adenosyl methionine as a key intermediate. FEBS Lett. 2009;583(8):1215–25.PubMedCrossRef Obeid R, Herrmann W. Homocysteine and lipids: S-adenosyl methionine as a key intermediate. FEBS Lett. 2009;583(8):1215–25.PubMedCrossRef
52.
go back to reference Kimball SR, Jefferson LS. Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis. J Nutr. 2006;136(1):227S-231S.PubMedCrossRef Kimball SR, Jefferson LS. Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis. J Nutr. 2006;136(1):227S-231S.PubMedCrossRef
53.
go back to reference Shanshan D, et al. Effects of histidine supplementation on global serum and urine 1H NMR-based metabolomics and serum amino acid profiles in obese women from a randomized controlled study. 2017. Shanshan D, et al. Effects of histidine supplementation on global serum and urine 1H NMR-based metabolomics and serum amino acid profiles in obese women from a randomized controlled study. 2017.
54.
go back to reference Javidan AN, et al. Is the pattern of dietary amino acids intake associated with serum lipid profile and blood pressure among individuals with spinal cord injury? J Spinal Cord Med. 2017;40(2):201–12.PubMedCrossRef Javidan AN, et al. Is the pattern of dietary amino acids intake associated with serum lipid profile and blood pressure among individuals with spinal cord injury? J Spinal Cord Med. 2017;40(2):201–12.PubMedCrossRef
55.
go back to reference Bel-Serrat S, et al. The role of dietary fat on the association between dietary amino acids and serum lipid profile in European adolescents participating in the HELENA Study. Eur J Clin Nutr. 2014;68(4):464–73.PubMedCrossRef Bel-Serrat S, et al. The role of dietary fat on the association between dietary amino acids and serum lipid profile in European adolescents participating in the HELENA Study. Eur J Clin Nutr. 2014;68(4):464–73.PubMedCrossRef
56.
go back to reference Leszczynski D, Kummerow F. Excess dietary lysine induces hypercholesterolemia in chickens. Experientia. 1982;38(2):266–7.PubMedCrossRef Leszczynski D, Kummerow F. Excess dietary lysine induces hypercholesterolemia in chickens. Experientia. 1982;38(2):266–7.PubMedCrossRef
57.
go back to reference Giroux I, Kurowska EM, Carroll KK. Role of dietary lysine, methionine, and arginine in the regulation of hypercholesterolemia in rabbits. J Nutr Biochem. 1999;10(3):166–71.PubMedCrossRef Giroux I, Kurowska EM, Carroll KK. Role of dietary lysine, methionine, and arginine in the regulation of hypercholesterolemia in rabbits. J Nutr Biochem. 1999;10(3):166–71.PubMedCrossRef
58.
59.
go back to reference Venho B, et al. Arginine intake, blood pressure, and the incidence of acute coronary events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr. 2002;76(2):359–64.PubMedCrossRef Venho B, et al. Arginine intake, blood pressure, and the incidence of acute coronary events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr. 2002;76(2):359–64.PubMedCrossRef
60.
go back to reference Vega-López S, et al. Altering dietary lysine: arginine ratio has little effect on cardiovascular risk factors and vascular reactivity in moderately hypercholesterolemic adults. Atherosclerosis. 2010;210(2):555–62.PubMedCrossRef Vega-López S, et al. Altering dietary lysine: arginine ratio has little effect on cardiovascular risk factors and vascular reactivity in moderately hypercholesterolemic adults. Atherosclerosis. 2010;210(2):555–62.PubMedCrossRef
Metadata
Title
Dietary amino acid patterns and cardiometabolic risk factors among subjects with obesity; a cross-sectional study
Authors
Fatemeh Abdi
Milad Mohammadzadeh
Mahdieh Abbasalizad-Farhangi
Publication date
01-12-2024
Publisher
BioMed Central
Keywords
Obesity
Obesity
Published in
BMC Endocrine Disorders / Issue 1/2024
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-024-01549-w

Other articles of this Issue 1/2024

BMC Endocrine Disorders 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.